Trigeminal ganglion neuron subtype-specific alterations of Ca V2.1 calcium current and excitability in aCacna1amouse model of migraine

Journal of Physiology

Volumn 589, Issue 23, 2011, Pages 5879-5895

  Fioretti, B ^a,b   Catacuzzeno, L ^b   Sforna, L ^a,b   Gerke Duncan, M B ^c   van den Maagdenberg, A M J M ^d   Franciolini, F ^b   Connor, M ^c   Pietrobon, D ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF SYDNEY   (Australia)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL CAV2.1; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CALCIUM CHANNEL T TYPE; CAPSAICIN; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACNA1A GENE; CELL SUBPOPULATION; CONTROLLED STUDY; DEPOLARIZATION; DEVELOPMENTAL GENE; DURA MATER; ELECTRIC POTENTIAL; FAMILIAL HEMIPLEGIC MIGRAINE; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENE MUTATION; MALE; MENINX; MIGRAINE; MOUSE; NERVE EXCITABILITY; NOCICEPTIVE RECEPTOR; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; TRIGEMINUS GANGLION; VASODILATATION;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CALCIUM CHANNELS, N-TYPE; CALCIUM CHANNELS, P-TYPE; CALCIUM CHANNELS, Q-TYPE; CAPSAICIN; CEREBELLAR ATAXIA; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MIGRAINE DISORDERS; MUTATION; NEURONS; TRIGEMINAL GANGLION;

EID: 82455174126     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.220533     Document Type: Article

References (56)

1. V2.1 P/Q-type calcium channel alternative splicing affects the functional impact of familial hemiplegic migraine mutations: implications for calcium channelopathies. Channels (Austin) 3, 110-121.
2. Akerman S, Kaube H & Goadsby PJ (2004). Anandamide acts as a vasodilator of dural blood vesselsin vivoby activating TRPV1 receptors. Br J Pharmacol 142, 1354-1360.
3. Akerman S, Williamson DJ & Goadsby PJ (2003a). Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism. Br J Pharmacol 140, 558-566.
4. Akerman S, Williamson DJ & Goadsby PJ (2003b). Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation. Br J Pharmacol 140, 718-724.
5. Ayata C (2009). Spreading depression: from serendipity to targeted therapy in migraine prophylaxis. Cephalalgia 29, 1095-1114.
6. Bellamy J, Bowen EJ, Russo AF & Durham PL (2006). Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons. Eur J Neurosci 23, 2057-2066.
7. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA & Moskowitz MA (2002). Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 8, 136-142.
8. Borgland SL, Connor M & Christie MJ (2001). Nociceptin inhibits calcium channel currents in a subpopulation of small nociceptive trigeminal ganglion neurons in mouse. J Physiol 536, 35-47.
9. Bove GM & Moskowitz MA (1997). Primary afferent neurons innervating guinea pig dura. J Neurophysiol 77, 299-308.
10. Capuano A, De Corato A, Lisi L, Tringali G, Navarra P & Dello Russo C (2009). Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology. Mol Pain 5, 43.
11. + currents generates distinct firing patterns in different subtypes of adult mouse trigeminal ganglion neurones. J Physiol 586, 5101-5118.
12. Ceruti S, Villa G, Fumagalli M, Colombo L, Magni G, Zanardelli M et al (2011). Calcitonin gene-related peptide-mediated enhancement of purinergic neuron/glia communication by the algogenic factor bradykinin in mouse trigeminal ganglia from wild-type and R192Q Cav2.1 knock-in mice: implications for basic mechanisms of migraine pain. J Neurosci 31, 3638-3649.
13. Dux M, Rosta J, Sántha P & Jancsó G (2009). Involvement of capsaicin-sensitive afferent nerves in the proteinase-activated receptor 2-mediated vasodilatation in the rat dura mater. Neuroscience 161, 887-894.
14. Dux M, Sántha P & Jancsó G (2003). Capsaicin-sensitive neurogenic sensory vasodilatation in the dura mater of the rat. J Physiol 552, 859-867.
15. Eberhardt M, Hoffmann T, Sauer SK, Messlinger K, Reeh PW & Fischer MJM (2008). Calcitonin gene-related peptide release from intact isolated dorsal root and trigeminal ganglia. Neuropeptides 42, 311-317.
16. 2 from rat dura mater encephali following electrical and chemical stimulation in vitro. Neuroscience 89, 901-907.
17. Eikermann-Haerter K, Dilekoz E, Kudo C, Savitz SI, Waeber C, Baum MJ et al (2009). Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J Clin Invest 119, 99-109.
18. Fabbretti E, D'Arco M, Fabbro A, Simonetti M, Nistri A & Giniatullin R (2006). Delayed upregulation of ATP P2X3 receptors of trigeminal sensory neurons by calcitonin gene-related peptide. J Neurosci 26, 6163-6171.
19. Fletcher CF, Tottene A, Lennon VA, Wilson SM, Dubel SJ, Paylor R et al (2001). Dystonia and cerebellar atrophy in Cacna1a null mice lacking P/Q calcium channel activity. FASEB J 15, 1288-1290.
20. Grigaliunas A, Bradley RM, MacCallum DK & Mistretta CM (2002). Distinctive neurophysiological properties of embryonic trigeminal and geniculate neurons in culture. J Neurophysiol 88, 2058-2074.
21. Hamill O, Marty A, Neher E, Sakmann B & Sigworth F (1981). Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391, 85-100.
22. Ho TW, Edvinsson L & Goadsby PJ (2010). CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol 6, 573-582.
23. Hong KW, Kim CD, Rhim BY & Lee WS (1999). Effect of w-conotoxin GVIA and w-agatoxin IVA on the capsaicin-sensitive calcitonin gene-related peptide release and autoregulatory vasodilation in rat pial arteries. J Cereb Blood Flow Metab 19, 53-60.
24. V2.1 knock-in mice is related to the shape of the action potential. J Neurophysiol 104, 291-299.
25. Iwasaki S, Momiyama A, Uchitel OD, & Takahashi T (2000). Developmental changes in calcium channel types mediating central synaptic transmission. J Neurosci 20, 59-65.
26. Jansen I, Alafaci C, Uddman R & Edvinsson L (1990). Evidence that calcitonin gene-related peptide contributes to the capsaicin-induced relaxation of guinea pig cerebral arteries. Regul Pept 31, 167-78.
27. Lauritzen M (1994). Pathophysiology of the migraine aura. The spreading depression theory. Brain 117, 199-210.
28. Lennerz JK, Ruhle V, Ceppa EP, Neuhuber WL, Bunnett NW, Grady EF & Messlinger K (2008). Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 507, 1277-1299.
29. Levy D (2009). Migraine pain, meningeal inflammation, and mast cells. Curr Pain Headache Rep 13, 237-240.
30. Levy D, Burstein R, Kainz V, Jakubowski M & Strassman AM (2007). Mast cell degranulation activates a pain pathway underlying migraine headache. Pain 130, 166-176.
31. Levy D & Strassman AM (2002). Mechanical response properties of A and C primary afferent neurons innervating the rat intracranial dura. J Neurophysiol 88, 3021-3031.
32. Li J, Vause CV & Durham PL (2008). Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res 1196, 22-32.
33. Matsuka Y, Neubert JK, Maidment NT & Spigelman I (2001). Concurrent release of ATP and substance P within trigeminal ganglia in vivo. Brain Res 915, 248-255.
34. Messlinger K, Hanesch U, Baumgärtel M, Trost B & Schmidt RF (1993). Innervation of the dura mater encephali of cat and rat: ultrastructure and calcitonin gene-related peptide-like and substance P-like immunoreactivity. Anat Embryol (Berl) 188, 219-237.
35. 2+ channel gating: evidence for b-subunit isoform-specific effects. J Biol Chem 279, 51844-51850.
36. Neher E (1992). Correction for liquid junction potentials in patch clamp experiments. Methods Enzymol 207, 123-131.
37. Neubert JK, Maidment NT, Matsuka Y, Adelson DW, Kruger L & Spigelman I (2000). Inflammation-induced changes in primary afferent-evoked release of substance P within trigeminal gangliain vivo. Brain Res 871, 181-191.
38. Olesen J, Burstein R, Ashina M & Tfelt-Hansen P (2009). Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurol 8, 679-690.
39. 2+ channel gene CACNL1A4. Cell 87, 543-552.
40. Pietrobon D (2005). Function and dysfunction of synaptic calcium channels: insights from mouse models. Curr Opin Neurobiol 15, 257-265.
41. V2.1 calcium channel function from mouse models of familial hemiplegic migraine. J Physiol 588, 1871-1878.
42. Pietrobon D & Striessnig J (2003). Neurobiology of migraine. Nat Rev Neurosci 4, 386-398.
43. Shimizu T, Toriumi H, Sato H, Shibata M, Nagata E, Gotoh K & Suzuki N (2007). Distribution and origin of TRPV1 receptor-containing nerve fibers in the dura mater of rat. Brain Res 1173, 84-91.
44. Strassman AM & Levy D (2006). Response properties of dural nociceptors in relation to headache. J Neurophysiol 95, 1298-1306.
45. Strassman AM, Raymond SA & Burstein R (1996). Sensitization of meningeal sensory neurons and the origin of headaches. Nature 384, 560-564.
46. v2.1 knockin migraine mice. Neuron 61, 762-773.
47. 2+ influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proc Natl Acad Sci U S A 99, 13284-13289.
48. Ulrich-Lai YM, Flores CM, Harding-Rose CA, Goodis HE & Hargreaves KM (2001). Capsaicin-evoked release of immunoreactive calcitonin gene-related peptide from rat trigeminal ganglion: evidence for intraganglionic neurotransmission. Pain 91, 219-226.
49. van den Maagdenberg AM, Pietrobon D, Pizzorusso T, Kaja S, Broos LA, Cesetti T et al (2004). A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 41, 701-710.
50. v2.1 S218L mice. Ann Neurol 67, 85-98.
51. Villalón CM & Olesen J (2009). The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs. Pharmacol Ther 124, 309-323.
52. 1A subunits of brain calcium channels. J Neurosci 15, 6403-6418.
53. Xiao Y, Richter JA & Hurley JH (2008). Release of glutamate and CGRP from trigeminal ganglion neurons: Role of calcium channels and 5-HT1 receptor signaling. Mol Pain 4, 12.
54. Zhang X, Levy D, Kainz V, Noseda R, Jakubowski M & Burstein R (2011). Activation of central trigeminovascular neurons by cortical spreading depression. Ann Neurol 69, 855-865.
55. Zhang X, Levy D, Noseda R, Kainz V, Jakubowski M & Burstein R (2010). Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura. J Neurosci 30, 8807-8814.
56. Zhang Z, Winborn CS, Marquez de Prado B & Russo AF (2007). Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. J Neurosci 27, 2693-2703.